Literature DB >> 17982184

Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction.

James G Jollis1, Mayme L Roettig, Akinyele O Aluko, Kevin J Anstrom, Robert J Applegate, Joseph D Babb, Peter B Berger, David J Bohle, Sidney M Fletcher, J Lee Garvey, William R Hathaway, James W Hoekstra, Robert V Kelly, William T Maddox, Joseph R Shiber, F Scott Valeri, Bradley A Watling, B Hadley Wilson, Christopher B Granger.   

Abstract

CONTEXT: Despite 2 decades of evidence demonstrating benefits from prompt coronary reperfusion, registries continue to show that many patients with ST-segment elevation myocardial infarction (STEMI) are treated too slowly or not at all.
OBJECTIVE: To establish a statewide system for reperfusion, as exists for trauma care, to overcome systematic barriers. DESIGN AND
SETTING: A quality improvement study that examined the change in speed and rate of coronary reperfusion after system implementation in 5 regions in North Carolina involving 65 hospitals and associated emergency medical systems (10 percutaneous coronary intervention [PCI] hospitals and 55 non-PCI hospitals). PATIENTS: A total of 1164 patients with STEMI (579 preintervention and 585 postintervention) eligible for reperfusion were treated at PCI hospitals (median age 61 years, 31% women, 4% Killip class III or IV). A total of 925 patients with STEMI (518 preintervention and 407 postintervention) were treated at non-PCI hospitals (median age 62 years, 32% women, 4% Killip class III or IV).
INTERVENTIONS: Early diagnosis and the most expedient coronary reperfusion method at each point of care: emergency medical systems, emergency department, catheterization laboratory, and transfer. Within 5 regions, PCI hospitals agreed to provide single-call catheterization laboratory activation by emergency medical personnel, accept patients regardless of bed availability, and improve STEMI care for the entire region regardless of hospital affiliation. MAIN OUTCOME MEASURES: Reperfusion times and rates 3 months before (July to September 2005) and 3 months after (January to March 2007) a year-long implementation.
RESULTS: Median reperfusion times significantly improved according to first door-to-device (presenting to PCI hospital 85 to 74 minutes, P < .001; transferred to PCI hospital 165 to 128 minutes, P < .001), door-to-needle in non-PCI hospitals (35 to 29 minutes, P = .002), and door-in to door-out for patients transferred from non-PCI hospitals (120 to 71 minutes, P < .001). Nonreperfusion rates were unchanged (15%) in non-PCI hospitals and decreased from 23% to 11% in the PCI hospitals. For patients presenting to or transferred to PCI hospitals, clinical outcomes including death, cardiac arrest, and cardiogenic shock did not significantly change following the intervention.
CONCLUSIONS: A statewide program focused on regional systems for reperfusion for STEMI can significantly improve quality of care. Further research is needed to ensure that programs that result in improved application of reperfusion treatments will lead to reductions in mortality and morbidity from STEMI.

Entities:  

Mesh:

Year:  2007        PMID: 17982184     DOI: 10.1001/jama.298.20.joc70124

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  68 in total

1.  Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes.

Authors:  Prashant Kaul; Jerome J Federspiel; Xuming Dai; Sally C Stearns; Sidney C Smith; Michael Yeung; Hadi Beyhaghi; Lei Zhou; George A Stouffer
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

2.  National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention.

Authors:  Jeph Herrin; Lauren E Miller; Dima F Turkmani; Wato Nsa; Elizabeth E Drye; Susannah M Bernheim; Shari M Ling; Michael T Rapp; Lein F Han; Dale W Bratzler; Elizabeth H Bradley; Brahmajee K Nallamothu; Henry H Ting; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2011-11-28

3.  ST-elevation myocardial infarction: is there time for Q waves?

Authors:  Mathew Mercuri; Madhu K Natarajan; James L Velianou
Journal:  CMAJ       Date:  2012-04-30       Impact factor: 8.262

4.  The impact of emergency medical services on the ED care of severe sepsis.

Authors:  Jonathan R Studnek; Melanie R Artho; Craymon L Garner; Alan E Jones
Journal:  Am J Emerg Med       Date:  2010-10-27       Impact factor: 2.469

5.  Percutaneous coronary intervention without onsite surgical backup.

Authors:  Gregory J Dehmer
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

6.  Why and when PCI, why and when thrombolysis?: thrombolysis.

Authors:  Giovanni Melandri; Franco Semprini; Samuele Nanni; Daniela Calabrese; Fabio Vagnarelli; Angelo Branzi
Journal:  Intern Emerg Med       Date:  2008-11-01       Impact factor: 3.397

7.  A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals.

Authors:  Dennis T Ko; Linda R Donovan; Thao Huynh; Stéphane Rinfret; Derek Y So; Michael P Love; Diane Galbraith; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-11       Impact factor: 5.223

Review 8.  Pre PCI hospital antithrombotic therapy for ST elevation myocardial infarction: striving for consensus.

Authors:  S Michael Gharacholou; Brenda J Larson; Christian C Zuver; Ryan J Wubben; Giorgio Gimelli; Amish N Raval
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

9.  Association between treatment at an ST-segment elevation myocardial infarction center and neurologic recovery after out-of-hospital cardiac arrest.

Authors:  Bryn E Mumma; Deborah B Diercks; Machelle D Wilson; James F Holmes
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

10.  Significance of off-hours in centralized primary percutaneous coronary intervention network.

Authors:  David Becker; Pal Soos; Balazs Berta; Andrea Nagy; Gabor Fulop; Gyorgy Szabo; Gyorgy Barczi; Eva Belicza; Istvan Martai; Béla Merkely
Journal:  Croat Med J       Date:  2009-10       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.